1. Physicians' Desk Reference. Oradell, NJ: Medical Economics, Inc.; 1997:2185-2187.
2.
2. Ribon A, Parikh S. Drug-induced asthma: a review. Ann Allergy. 1980; 44:220-224.
3.
3. Kuzemko J. Twenty years of sodium cromoglycate treatment: a short review. Respir Med. 1989;83(Suppl):11-16.
4.
4. Hyde J, Swarts C. Long-term prophylaxis of childhood asthma using cromolyn sodium. Ann Allergy. 1971; 29:483-491.
5.
5. Smith J, Pizarro Y. Observations on the safety of disodium cromoglycate in long-term use in children. Clin Allerg. 1972;2:143-151.
6.
6. Toogood J. Multi-centre surveillance of long-term safety of sodium cromoglycate. Acta Allergol. 1977;13(Suppl): 44-54.
7.
7. Sheffer A, Rocklin R, Goetzl E. Immunologic components of hypersensitivity reactions to cromolyn sodium. N Engl J Med. 1975;293:1220-1224.
8.
8. Menon M, Das A. Asthma and urticaria during disodium cromoglycate treatment: a case report. Scand J Resp Dis. 1977;58:145-150.
9.
9. Wass U, Plaschke P, Bjorkander J, Belin L. Assay of specific IgE antibodies to disodium cromoglycate in serum from a patient with an immediate hypersensitivity reaction. J Allergy Clin ImmunoL1988;81:750-757.
10.
10. Ibanez M, Laso T, Martinez-San Irineo M, Alonso E. Anaphylaxis to disodium cromoglycate. Ann Allergy Asthma Immunol. 1996;77:185-186.
11.
11. Block S. Nasal congestion as a side effect of cromolyn sodium. JAllergy Clin Immunol. 1974;53:243-244.
12.
12. Muller J, Kowalski J. Unusual side effects during disodium cromoglycate (Intal) therapy in a case of bronchial asthma (case report). Pneumonologie. 1975;151:323-328.
13.
13. Price H. Asthma attacks precipitated by disodium cromoglycate in a boy with alpha-1-antitrypsin deficiency (letter). Lancet. 1982;2:606-607.
14.
14. Skaarpas I. An unexpected reaction towards disodium cromoglycate. Allergy. 1987;42:318-319.
15.
15. Mansfield L. Disappearence of allergic reaction to cromolyn (cromogly-cate) by avoidance and then reintroduction.J Asthma. 1991;28:447-450.
16.
16. Brown L, Kaplan R, Benjamin P, et al. Immunoglobulin E-mediated anaphylaxis with inhaled cromolyn sodium. J Allergy Clin Immuno L1981;68:416-420.
17.
17. Ahmad S. Cromolyn sodium and anaphylaxis (letter). Ann Int Med. 1983;99:882-882.
18.
18. Repo U, Nieminen P. Pulmonary infiltrates with eosinophilia and urinary symptoms during disodium cromoglycate treatment: a case report. Scand J Resp Dis. 1976;57:1-4.
19.
19. Lobel H, Machtey I, Eldror M. Pulmonary infiltrates with eosinophilia in an asthmatic patient treated with disodium cromoglycate (letter). Lancet. 1972;2:1032.
20.
20. Burgher L, Kass I, Schenken J. Pulmonary allergic granulomatosis: a possible drug reaction in a patient receiving cromolyn sodium. Chest. 1974;66:84-86.
21.
21. Settipane G, Klein D, Boyd G, et al. Adverse reactions to cromolyn. JAMA. 1979;241:811-813.
22.
22. Rao M, Steiner P, Victoria M. Nasal congestion as a side effect of cromolyn sodium in a pediatric patient (letter).JPediatr. 1975;86:804-804.
23.
23. Block S. Side effects of cromolyn sodium therapy (letter). J Pediatr. 1975;87:502-502.
24.
24. Block S. Urethral burning as a side effect of cromolyn sodium (letter). Am Rev Respir Dis. 1974;109:581-581.
25.
25. Moss G, Jones K, Ritchie J, Cox S. Plasma levels and urinary excretion of disodium cromoglycate after inhalation by human volunteers. Toxicol Appl Pharmacol. 1971;20:147-156.
26.
26. Clark B, Neale M. Hepatic and renal clearence of sodium cromoglycate. JPharm Pharmacol. 1981;33:744-745.
27.
27. Moss C,Jones K, Ritchie J, Cox S. Distribution and metabolism of disodium cromoglycate in rats. Toxicol Appl Pharmacol. 1970;17:691-698.
28.
28. Levinsky H, MacFarland H, Procter B, et al. A study of the chronic toxicity of inhaled disodium cromoglycate in the squirrel monkey. Toxicol Appl Pharmacol. 1978;45:141-153.
29.
29. Goldstein R, Paul W, Metcalfe D, et al. NIH conference. Asthma. Ann Int Med. 1994;121:698-708.
30.
30. Beach J, Blair A, Clarke A, Bonfield C. Cromolyn sodium toxicity studies in primates. Toxicol Appl Pharmacol. 1981;57:367-400.
31.
31. Hutchinson H, Bedford S, Kuzemko J, Walsh M. Renal tubular function in asthmatic children on long-term disodium cromoglycate. Clin Allergy. 1972;2:91-93.
32.
32. Hyde J, Floro L. Pros and cons of cromolyn sodium prophylaxis: a summary of experiences with 70 asthmatic children. Clin Ped. 1973;12:525-528.
33.
33. Slater E. Cardiac tamponade and peripheral eosinophilia in a patient receiving cromolyn sodium. Chest. 1978;73:878-879.
34.
34. Rosenberg J, Edlow D, Sneider R. Liver disease and vasculitis in a patient taking cromolyn. Arch Intern Med. 1978;138:989-991.
35.
35. Israel R, Wood J. Esophagitis related to cromolyn. JAMA. 1979;242:2758-2759.
36.
36. National Heart, Lung, and Blood Institute. Guidelines for the Diagnosis and Management of Asthma. 1991; NIH publication91-3042.
37.
37. National Institutes of Health. International Consensus Report on the Diagnosis and Management of Asthma. 1992; NIH publication92-3091.
38.
38. Sly R. Changing asthma mortality and sales of inhaled bronchodilators and anti-asthmatic drugs. Ann Allergy. 1994;73:439-443.
39.
39. Asmus M, Teresi M, Milavetz G, Ahrens R. How will the CFC ban affect MDIs. J Respir Dis. 1996;17:34-37.